161 related articles for article (PubMed ID: 30930112)
1. Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo.
Takai T; Tsujino T; Yoshikawa Y; Inamoto T; Sugito N; Kuranaga Y; Heishima K; Soga T; Hayashi K; Miyata K; Kataoka K; Azuma H; Akao Y
Mol Ther; 2019 May; 27(5):1017-1027. PubMed ID: 30930112
[TBL] [Abstract][Full Text] [Related]
2. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
[TBL] [Abstract][Full Text] [Related]
3. MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1.
Sugiyama T; Taniguchi K; Matsuhashi N; Tajirika T; Futamura M; Takai T; Akao Y; Yoshida K
Cancer Sci; 2016 Dec; 107(12):1767-1775. PubMed ID: 27696637
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
[TBL] [Abstract][Full Text] [Related]
5. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
Minami K; Taniguchi K; Sugito N; Kuranaga Y; Inamoto T; Takahara K; Takai T; Yoshikawa Y; Kiyama S; Akao Y; Azuma H
Oncotarget; 2017 May; 8(20):33064-33077. PubMed ID: 28380435
[TBL] [Abstract][Full Text] [Related]
6. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
[TBL] [Abstract][Full Text] [Related]
7. Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143.
Akao Y; Kumazaki M; Shinohara H; Sugito N; Kuranaga Y; Tsujino T; Yoshikawa Y; Kitade Y
Cancer Sci; 2018 May; 109(5):1455-1467. PubMed ID: 29498789
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
[TBL] [Abstract][Full Text] [Related]
10. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
[TBL] [Abstract][Full Text] [Related]
11. miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.
Chen X; Shi J; Zhong J; Huang Z; Luo X; Huang Y; Feng S; Shao J; Liu D
Int J Exp Pathol; 2015 Dec; 96(6):427-32. PubMed ID: 26852690
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
[TBL] [Abstract][Full Text] [Related]
13. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
Zhai W; Ma J; Zhu R; Xu C; Zhang J; Chen Y; Chen Z; Gong D; Zheng J; Chen C; Li S; Li B; Huang Y; Xue W; Zheng J
Br J Cancer; 2018 Aug; 119(5):591-604. PubMed ID: 30082686
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.
Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C
Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041
[TBL] [Abstract][Full Text] [Related]
15. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
[TBL] [Abstract][Full Text] [Related]
16. PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.
Taniguchi K; Sakai M; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakayama T; Ueda H; Nakagawa Y; Ito Y; Futamura M; Uno B; Otsuki Y; Yoshida K; Uchiyama K; Akao Y
Oncotarget; 2016 Apr; 7(14):18940-52. PubMed ID: 26980745
[TBL] [Abstract][Full Text] [Related]
17. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
18. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
[TBL] [Abstract][Full Text] [Related]
19. MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras.
Fang Y; Sun B; Li Z; Chen Z; Xiang J
Mol Carcinog; 2016 Sep; 55(9):1369-77. PubMed ID: 26333174
[TBL] [Abstract][Full Text] [Related]
20. BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
Liu Y; Zhao R; Wei Y; Li M; Wang H; Niu W; Zhou Y; Qiu Y; Fan S; Zhan Y; Xiong W; Zhou Y; Li X; Li Z; Li G; Zhou M
J Exp Clin Cancer Res; 2018 Mar; 37(1):64. PubMed ID: 29559001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
